Real-time enrollment status for this lymphoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:27 PM UTC
| NCT Number | NCT04104776 |
| Recruiting Status | Recruiting |
| Condition | Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 300 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 17, 2026 (Yesterday) |
As of July 18, 2026: Clinical trial NCT04104776 is currently recruiting participants. This phase1 study for lymphoma is actively seeking new participants at 22 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04104776 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04104776 was last updated Yesterday (July 17, 2026). HelloStudys verifies this status automatically.